Chief Financial Officer
Tricia joined CRI Worldwide (now CRI Lifetree) in July 2010 as its Chief Financial Officer. Tricia has almost 20 years of financial management experience in the biopharmaceutical and drug development sectors. Her experience includes assisting in raising public and private equity and debt, financial evaluation of business development opportunities, including acquisitions and mergers, cash and risk management, SEC and management reporting, and Sarbanes-Oxley compliance.
Before joining CRI, Tricia held various financial management positions with Neose Technologies, Inc., Novavax, Inc. and Charles River Laboratories. Tricia started her career with Laventhol & Horwarth, CPA after earning a BA in Business, from the University of Florida. She is a Certified Public Accountant.